Floatz logo

Fosfomycin

Right-sided Colon Adenoma

Zealand University HospitalSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Right-sided Colon Adenoma cohort.

Asset / SponsorPhaseRating
Acetylsalicylic Acid
National Cancer Institute (NCI)
Phase 3BB
MARBLE DUST
Colotech A/S
Phase 3BB
SODIUM PICOSULFATE HYDRATE
Korea University Anam Hospital
Phase 3BB
PEG-Ascorbate
Korea University Anam Hospital
Phase 3BB
MACROGOLS
Korea University Anam Hospital
Phase 3BB

View all 17 →

Same molecule, other indications

Fosfomycin is also rated in:

infectious diseaseDormant
BB
Indicative ·
69 / 100
View asset →
bacterial urinary tract infectionDormant
B
Indicative ·
60 / 100
View asset →
chronic prostatitisDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →